Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.

Nat Med · 2026 · PMC12823385 · PMID 41326666

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, parietal lobe (1,978 mm 3 ; 95% confidence interval: 360.12−3,597.67; unadjusted P = 0.018) and frontoparietal lobe (4,272 mm 3 ; 95% confidence interval: 722.41−7,820.64; unadjusted P = 0.02) showed a trend of lower reduction in volume.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.